DataMEDS AI, Inc. (MEDS)
NASDAQ: MEDS · Real-Time Price · USD
3.580
-4.010 (-52.83%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Company Description
DataMEDS AI, Inc. operates as a health IT company in the United States.
The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers.
It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI.
It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026.
DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.
DataMEDS AI, Inc.
| Country | United States |
| Founded | 2022 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
Contact Details
Address: 3000 Bayport Drive, Suite 950 Tampa, Florida 33607 United States | |
| Phone | 844 203 6092 |
| Website | datamedsai.com |
Stock Details
| Ticker Symbol | MEDS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001382574 |
| CUSIP Number | 89846A405 |
| ISIN Number | US89846A4058 |
Key Executives
| Name | Position |
|---|---|
| Surendra K. Ajjarapu | Chairman and Chief Executive Officer |
| Prashant Patel R.Ph. | Interim Chief Financial Officer, President, Chief Operating Officer and Director |